Newsfeeds - Spark Newswire

2 minute read

What Are Whales Doing With Becton, Dickinson

Today, 8:34 AM

Someone with a lot of money to spend has taken a bearish stance on Becton, Dickinson (NYSE:BDX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

BDX

7 minute read

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30

By Akanksha Bakshi

Today, 8:34 AM

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

AAPL

1 minute read

Becton Dickinson To Pay $4.8M In Hernia Mesh Lawsuit, Second Within Six Months

By Vandana Singh

Today, 8:34 AM

Becton Dickinson and Co's (NYSE: BDX) unit, C.R. Bard Inc, was ordered to pay $4.8 million in a lawsuit related to its hernia repair mesh. The company faces more than 30,000 similar lawsuits over its mesh hernia repair devices.

BDX

1 minute read

No More Free COVID-19 At-Home Tests, Federal Government Says

By Vandana Singh

Today, 8:34 AM

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

2 minute read

BD Launches First-in-Human Trial Of Sirolimus Drug-Coated Balloon To Expand Treatment Options For Peripheral Arterial Disease

By Benzinga Newsdesk

Today, 8:34 AM

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). BD is a

BDX

1 minute read

Goldman Sachs Maintains Buy on Becton, Dickinson, Raises Price Target to $319

By Benzinga Newsdesk

Today, 8:34 AM

Goldman Sachs analyst Amit Hazan maintains Becton, Dickinson (NYSE:BDX) with a Buy and raises the price target from $278 to $319.

BDX

1 minute read

Why Accelerate Diagnostics Shares Are Trading Higher Today

By Vandana Singh

Today, 8:34 AM

Becton Dickinson and Co (NYSE:BDX) will sell Accelerate Diagnostics Inc’s (NASDAQ:AXDX) rapid testing solution for antibiotic resistance and susceptibility, offering results in…

AXDX

2 minute read

BD, Accelerate Diagnostics Announce Global Commercial Collaboration

By Benzinga Newsdesk

Today, 8:34 AM

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ:AXDX) an innovator of rapid in-vitro diagnostics in microbiology, today announced a

AXDX

2 minute read

Animal Spirits: Nasdaq Up 19% Off June Lows

By GRIT Capital

Today, 8:34 AM

MARKET UPDATE After a 3-week S&P 500 rally, U.S. markets catching Canadian market Year-to-date in Canadian dollars S&P…

$ADA

1 minute read

Recap: Becton, Dickinson Q3 Earnings

By Benzinga Insights

Today, 8:34 AM

Becton, Dickinson (NYSE:BDX) reported its Q3 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

BDX